Intepat

APRIL 23, 2024

This principle was firmly established by the Supreme Court of India in the landmark decision of Cadila Health Care Limited vs. Cadila Pharmaceuticals Limited (2001). In this case, the court highlighted the pivotal role of careful branding in the pharmaceutical Industry. In the case of Anafortan v.

Branding 52

Branding Brands Branding Trademark 52

SpicyIP

AUGUST 22, 2021

Sun Pharma v. In the recent case of Sun Pharmaceuticals Industries Ltd. Cipla Ltd. , Cipla Ltd. , The Defendant Sun Pharmaceuticals Industries Ltd. allegedly infringed the Plaintiff Cipla Ltd.’s Kedar is a fourth year BLS LLB student at the Adv.

Marketing 139

Marketing Marketing Trademark Registering Trademarks 139

Selvam & Selvam Blog

APRIL 1, 2022

Recently, the Madras High Court, in the case of Sun Pharmaceuticals (Applicant/Defendant) v. Cipla Ltd (Respondent/Plaintiff) refused to vacate the interim injunction against the Applicant, Sun Pharmaceutical Industries. against Sun Pharma from using the mark till 2.06.21. Sun Pharma’s Contentions.

Intellectual Property 40

Intellectual Property IP Copyright Infringement Artistic Work 40

SpicyIP

JANUARY 2, 2022

The decisions in the first category , i.e., Top 10 IP Judgments/Orders (Topicality/Impact) reflect those that we thought were important from a topical point of view and were covered by the media in some way owing to the importance of parties litigating or the issue being considered or for impact on industry and innovation/creativity ecosystem etc.

IP 143

IP Intellectual Property Copyright Trademark 143

SpicyIP

AUGUST 30, 2021

Sun Pharma v. In this guest post , Kedar Ganesh Dhargalkar analyses the recent case of Sun Pharmaceuticals Industries Ltd. Cipla Ltd. , Cipla Ltd. , The Defendant Sun Pharmaceuticals Industries Ltd. allegedly infringed the Plaintiff Cipla Ltd.’s Topical Highlight.

Non-Fungible Tokens 105

Non-Fungible Tokens Fair Use Advertising Advertising 105

SpicyIP

MAY 15, 2023

SpicyIP intern Surmayi Khatana writes on this exciting news clarifying that the agreement is technically between ISRA and the Collective Rights Management Organization, PPL, and not the industry body IMI, as reported in the media. Case: Sun Pharma Laboratories Ltd vs Cian Healthcare Ltd & Anr.

Trademark 104

Trademark Registration Cease and Desist IP 104